title: Response of severe psoriasis to infliximab.
authors.forename: Ranz
authors.initials: R
authors.lastname: Mang
authors.forename: Helger
authors.initials: H
authors.lastname: Stege
authors.forename: Thomas
authors.initials: T
authors.lastname: Ruzicka
authors.forename: Jean
authors.initials: J
authors.lastname: Krutmann
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D015535:Arthritis, Psoriatic / Q000188:drug therapy* / Q000473:pathology; D003879:Dermatologic Agents / Q000627:therapeutic use*; D006801:Humans; D000069285:Infliximab; D007275:Injections, Intravenous; D008297:Male; D011565:Psoriasis / Q000188:drug therapy* / Q000473:pathology; D012720:Severity of Illness Index; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D000911:Antibodies, Monoclonal; D003879:Dermatologic Agents; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab